课题基金 / 基金详情

Novel Regenerative Treatment of TBI and Post TBI Depression

Novel Regenerative Treatment of TBI and Post TBI Depression
TBI 和 TBI 后抑郁症的新型再生治疗
批准号:
10623171
负责人:
Shan P. Yu
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-01 至 2023-03-31
关键词:
AccidentsAcuteAreaAstrocytesAthletic InjuriesAttenuatedAutologousAxonBehaviorBehavioralBrainBrain InjuriesBrain-Derived Neurotrophic FactorBypassCell TherapyCell TransplantationCellsChemicalsChronicChronic PhaseCicatrixCombined Modality TherapyContusionsDataDevelopmentEctopic ExpressionExerciseGene ExpressionGene Expression RegulationGenesGliosisGoalsHealthIn VitroInjectionsInjuryInvestigationLentivirus VectorLesionMental DepressionMental disordersMitoticModelingMusNatural regenerationNeurogliaNeuronal PlasticityNeuronsNeuroprotective AgentsOxytocinPatientsPharmacotherapyPhysiologicalPluripotent Stem CellsPost-Traumatic Stress DisordersRecovery of FunctionRegenerative MedicineRehabilitation therapyReportingResearchRiskSignal TransductionSiteSoldierSomatic CellSourceSpinal cord injuryStem cell transplantTBI PatientsTBI treatmentTestingTherapeuticTherapeutic EffectTissuesTransplantationTraumatic Brain InjuryUp-RegulationVeteransWaradult neurogenesisastrogliosisaxon growthaxon regenerationbasebehavior testbrain tissuecell typecentral nervous system injurychronic depressionclinical translationcombatcontrolled cortical impactdelivery vehicledisabilityeffective therapyexperimental studyimprovedin vivomiddle agemouse modelnerve stem cellneural networkneurogenesisneurovascular injurynovelnovel therapeuticspreventprotective effectpsychologicreconstructionregenerativeregenerative treatmentrepairedsexstroke therapysubventricular zonesuccesssynaptogenesistissue repairtranscription factortreadmilltumor

项目摘要

项目成果

Shan P. Yu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As soldiers are returning from wars around the globe, traumatic brain injury (TBI) has been reported among veterans. Brain structural damage of different degrees and functional/behavioral deficits such as post-traumatic stress disorder (PTSD) including post-TBI depression (PTD) are frequently seen among these patients. So far, there is basically no effective treatment for acute TBI or chronic patients. In recent years, cell-based therapy provides an attractive and coherent approach in regenerative medicine. Based on the latest advancement and our preliminary data, we propose a novel delayed treatment by directly converting endogenous astrocytes accumulated around the injury site into "induced neurons (iNs)" in the chronic phase after TBI. In a mild/moderate TBI mouse model, the direct reprogramming gene NeuroD1 (ND1) that targets reactive astrocytes will be expressed in the peri-contusion region by lentiviral injection. We hypothesize that the intra-lineage direct reprogramming provides a viable endogenous source of new neurons by leveraging existing proliferative astrocytes after TBI and helps to prevent the development of PTD (Specific Aim 1). We propose that the reprogramming gene expression will effectively reduce gliosis or glial scar formation during the chronic phase after TBI, which will lessen physical and chemical barriers for regeneration and significantly facilitate axonal outgrowth and other regenerative activities (Aim 2). It is further hypothesized that combined rehabilitation of treadmill exercise will improve ND1-induced gene regulation, post-TBI tissue repair and functional activities (Aim 3). We propose that, in the combination therapy, iNs arisen within the host tissue enriched by up-regulated genes such as BDNF and oxytocin are conducive to integration with existing neural networks. Our preliminary data demonstrate the feasibility of converting astrocytes into mature neurons, increased regenerative/behavioral genes, and improved psychological behaviors chronically after TBI. The goal of this investigation is to demonstrate and develop an effective treatment for veteran patients with TBI-related PTD.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Innovative memantine therapy for neuroprotective effects against ischemic stroke and Alzheimer's disease
  • 批准号:
    10480182
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    Shan P. Yu
  • 依托单位:
The role of NMDA receptor subunit GluN3A in age and Alzheimer's disease-related dementia
  • 批准号:
    10491045
  • 项目类别:
  • 资助金额:
    $19.56万
  • 财政年份:
    2021
  • 负责人:
    Shan P. Yu
  • 依托单位:
Novel Regenerative Treatment of TBI and Post TBI Depression
  • 批准号:
    10385693
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    Shan P. Yu
  • 依托单位:
Novel Regenerative Treatment of TBI and Post TBI Depression
  • 批准号:
    10060751
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    Shan P. Yu
  • 依托单位:
海外基金